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Introduction
Opioid drugs, including endogenous opioid peptides and the analgesic drug morphine, exert their pharmacological and physiological effects through binding to opioid receptors. The three major types of opioid receptors (mu, delta, and kappa) all belong to the G protein-coupled receptor superfamily. On agonist binding, these receptors couple to G proteins and affect several signal transduction pathways, including inhibition of adenylyl cyclases and Ca 2+ channels, activation of inward-rectifying K + channels, transient increases of intracellular Ca 2+ levels, and activation of phospholipase C and the mitogen-activated protein kinases ERK1 and ERK2 (Law et al., 2000) .
The mu opioid receptor (MOR) is expressed mainly in the central nervous system, with densities varying greatly in different brain regions displaying different functional roles (Mansour et al., 1995) . The MOR-expressing brain regions are involved in motivating and rewarding behaviors mediated by opiates and other drugs of abuse. Furthermore, response to morphine varies in different neuronal cells and brain regions depending on receptor levels. Several studies suggest that the mu opioid receptor (MOR) plays a key role in mediating the major clinical effects of morphine, as well as the development of tolerance and physical dependence on prolonged administration (Kieffer and Evans, 2002; Law et al., 2004) . The pharmacological effects of morphine are blocked in MOR knockout mice Matthes et al., 1996; Sora et al., 1997) , suggesting that the in vivo activities of morphine depend on the levels of the MOR. These observations suggest that regulation of MOR levels has a critical role in the cellular responses to chronic drug exposure.
MOR expression is also regulated temporally. In mice, MOR can be detected as early as embryonic day 8.5 (E8.5). After E8.5, MOR expression increases significantly throughout This article has not been copyedited and formatted. The final version may differ from this version. development and reaches maximal levels in the adult (Ko et al., 2002; Zhu et al., 1998) . Similar time-dependent regulatory patterns of MOR expression are seen in mouse embryonal carcinoma P19 cells during neuronal differentiation, increasing gradually to a maximum at day 4 of differentiation (Chen et al., 1999; Hwang et al., 2007) . Overall, MOR expression appears to be regulated both spatially and temporally by finely tuned mechanisms.
MOR activity is regulated at different levels, including epigenetic Hwang et al., 2009) , transcriptional Wei and Loh, 2002) , posttranscriptional Kim et al., 2008; Pan et al., 2001) , translational (Song et al., 2009a; Song et al., 2009b) , and even at the protein level by receptor phosphorylation and desensitization (Arden et al., 1995; El Kouhen et al., 2001) . The MOR gene contains many specific regulatory elements upstream of the promoter region, including regions mediated by
Oct-1 (Liang and Carr, 1996) , PU.1 , IL-4 (Kraus et al., 2001) , Sox , Sp1 , NF-κB (Kraus et al., 2003) , CREB (Lee and Lee, 2003) , PCBPs Choi et al., 2008) , and NRSF Kim et al., 2004 ).
Although the above several studies have reported that the MOR gene is regulated by various cisand trans-acting factors, critical questions remain unanswered such as changes in the chromatin conformation of the endogenous MOR gene locus in a physiologically relevant cell model, and the dynamics of transcription factors and chromatin remodelers during the activation process of this gene during neuronal differentiation.
Epigenetic features such as DNA methylation and histone modifications in particular play an important role in MOR gene activation in mouse P19 cells undergoing neuronal differentiation This study examines if DNA methylation and histone modifications of the MOR promoter region are concurrent with chromatin remodeling of the promoter region to provide access for transcription factors to the DNA. The chromatin structure of the MOR promoter in P19 cells was examined during neuronal differentiation to determine if differentiation induces chromatin remodeling of the promoter and, if so, which the factors were involved. The results indicate that differentiation induces recruitment of chromatin remodeling factors to the promoter and transcription factor involvement, ultimately leading to histone dissociation and subsequent activation of transcription.
Materials and methods
Cell culture and transfection-The procedures to differentiate P19 cells have been described previously (Chen et al., 1999; Hwang et al., 2007) . Briefly, P19 cells were cultured in minimal essential medium containing 7.5% newborn calf serum and 2.5% fetal calf serum at 37°C in a humidified atmosphere of 5% CO 2 . Cells were aggregated in bacteriological Petri dishes in minimal essential medium containing 5% heat-inactivated fetal bovine serum and 0.5 μM alltrans retinoic acid (RA) for 2 days; the treatment was repeated for another 2 days. After aggregation, the cells were dissociated using DNase I and trypsin/EDTA and plated in tissue This article has not been copyedited and formatted. The final version may differ from this version. and total RNA purifications. Treatments with 100 nM trichostatin A (TSA; Sigma) for 24 h were performed as described previously .
Neuroblastoma NMB cells were grown in RPMI 1640 medium with 10% fetal bovine serum (Invitrogen) in an atmosphere of 5% CO 2 /95% air at 37°C. Transfections into NMB cells for promoter analyses were performed as described previously . MOR promoter plasmid (p189) contains the DNA sequence from -450 bp to -189 bp upstream of the mouse MOR gene (relative to the translation start site at +1) in the luciferase reporter plasmid,
pGL3-basic (Promega).
Preparation of nuclei and nuclease digestion-These procedures were carried out as described previously (Gui and Dean, 2001; Park et al., 2005) with some modifications. Undifferentiated and differentiating P19 cells (1 to 4 days after plating) were crosslinked with 1% formaldehyde for 10 min, followed by the addition of 1.47 ml of 1 M glycine per 10 ml of culture medium to stop crosslinking. Populations consisted of undifferentiated (UD), intermediately differentiated (2 days after plating; AP2d), or fully differentiated (4 days after plating; AP4d) P19 cells. Nuclei isolated from approximately 10 8 cells (from four 10 cm-dishes) were suspended in 1 ml of wash buffer (10 mM Tris-HCl [pH 7.4], 15 mM NaCl, 50 mM KCl, 0.15 mM spermine, 0.5 mM spermidine, and 8.5% sucrose) and digested with micrococcal nuclease (MNase; 20-120 U;
Worthington Biochemical, Freehold, NJ) or DNase I (50-100 U/ml; Invitrogen) for 6 min at 37°C. Reactions were stopped by adding 100 μl of 5 M NaCl and 100 μl of stop solution (10% SDS, 125 mM EDTA, and 1 mg/ml proteinase K) and incubating for 3 h at 50°C. The
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Ligation-mediated PCR (LM-PCR)-
The procedures were performed as described previously (Carey et al., 2009) (Park et al., 2005) with minor modifications. The primer and linker oligonucleotides used are listed in Table 1 . For nucleosome mapping, 1 μg of MNase-digested DNA was phosphorylated and then ligated with annealed linker DNA (Linkers 1 and 2) overnight at 16°C. Ligated DNAs were amplified with PCR using primer 1 and Linker 1, as follows: 25 cycles, 1 min (4 min for the first cycle) at 95°C, 2 min at 63°C, 3 min at 76°C, and an additional 5 min extension at 76°C. Labeling was accomplished by adding [γ-32 P]ATP-3′-endlabeled primer 2 to the PCR reaction, and performing three more cycles as follows: 1 min (4 min for the first cycle) at 95°C, 2 min at 68°C, and 10 min at 76°C. Amplified and labeled DNA fragments were resolved in a 6% polyacrylamide/urea gel, followed by exposure to a PhosphorImager screen. LM-PCR using DNase I-digested nuclei was performed as described (Park et al., 2005) .
PCR-based survey of nucleosomes on the MOR promoter-Nuclei were treated with 120 U of MNase at 37°C for 30 min. Genomic DNAs corresponding to a mononucleosome (i.e., a 147-bp monomer) were cut from a 1.4% agarose gel and purified using the QIAquick gel extraction kit (Qiagen). The purified DNA was identified and quantified on an agarose gel. PCR amplification was performed by 30 cycles (30 s at 94°C, 30 s at 60°C, and 30 s at 72°C) using several primer sets (see Table 1 ). Purified monomers from UD, AP2d, and AP4d cells were used as template DNAs for real-time quantitative PCR with primer sets designed to detect the position of nucleosome N1.
This article has not been copyedited and formatted. The final version may differ from this version. Electrophoretic mobility shift assay (EMSA)-Nuclear extracts from P19 cells were prepared using a modification of Dignam's procedure (Dignam et al., 1983; Hennighausen and Lubon, 1987 Anti-MeCP2 (ab2828) and anti-Sp1 (07-645) antibodies were purchased from Abcam and Upstate, respectively.
Reverse transcription-PCR (RT-PCR) and real-time quantitative RT-PCR (qRT-PCR)-Total
RNA was isolated using TRI Reagent and analyzed by RT-PCR using the MOR gene-specific primers mMOR-S1 and mMOR-AS1 (covering exons 1 and 2, respectively; see Table 1 ) . RT-PCR was performed using a Qiagen OneStep RT-PCR kit. A similar reaction was carried out using primers for β-actin as an internal control . PCR products were analyzed by electrophoresis on 2% agarose gels.
This article has not been copyedited and formatted. The final version may differ from this version. For qRT-PCR, 5 μg of total RNA were treated with DNase I and reverse-transcribed using reverse transcriptase (Roche) and primers combined with oligo (dT) and random hexamer. Onefortieth of this reaction was used for real-time qRT-PCR analysis of gene expression. Real-time qPCR was performed in an iCycler (Bio-Rad) using SYBR Green I (Quantitect SYBR Green PCR kit; Qiagen). The primer sequences used were MOR_E3-S and MOR_E4-AS, covering exons 3 and 4, respectively (see Table 1 ). The specificity of RT-PCR primers was determined using a melt curve after the amplification to show that only a single species of qPCR product resulted from the reaction. Single PCR products were also verified on an agarose gel. The RT-PCR and real-time qRT-PCR experiments were repeated two or three times to obtain statistical significance.
Coimmunoprecipitation and chromatin immunoprecipitation (ChIP) assays-
Coimmunoprecipitation was performed as described previously (Hwang et al., 2009; Kim et al., 2006) . Briefly, P19 cells were lysed in a buffer containing 1% Triton X-100, 10 mM Tris, 5 mM EDTA, 50 mM NaCl, and 50 mM NaF, supplemented with protease inhibitors (Roche).
Approximately 1 mg of each clarified cell lysate was incubated overnight at 4°C with antibodies.
Immunoprecipitates were recovered on protein G-agarose beads, washed extensively and separated by SDS-PAGE. Proteins were transferred to Immobilon-P (PVDF; Millipore) membranes for western blotting.
ChIP assays were performed as reported previously Hwang et al., 2007; Kim et al., 2004) . A total of 1 × 10 6 cells were used for each ChIP assay. Cells were crosslinked with 1% formaldehyde. Sonicated cell extracts, normalized to contain equivalent amounts of protein, were precipitated with 2 μg of antibody at 4°C overnight, followed by the addition of protein G beads for 1 h. Two percent of each lysate was reserved as the input (i.e., This article has not been copyedited and formatted. The final version may differ from this version. Western blot analyses were performed on protein samples prepared as described . Proteins transferred to Immobilon-P membranes were incubated with primary antibodies and detected using an ECF western detection kit (Amersham). The antibodies used were anti-MeCP2 (ab2828, Abcam), Anti-Sp1 (07-645, Upstate), anti-Sp3 (sc-644 X, Santa
Cruz), and anti-β-actin (4967, Cell Signaling Technology). The membrane was scanned using a PhosphorImager.
Results
Chromatin structure of the mouse MOR gene. To examine the chromatin structure of MOR promoter before and after neuronal differentiation, limited MNase digestion coupled with This article has not been copyedited and formatted. The final version may differ from this version. Southern blot analyses were performed to map the location of nucleosomes in this region (Fig. 1 ).
Nuclei isolated from UD, AP2d and AP4d cells were treated with increasing amounts of MNase and stayed at the same level on day 5 (lane 8), as described previously , whereas β-actin mRNA was relatively constant. These results indicate that changes in the chromatin structure of the MOR promoter in differentiated neuronal cells lead to increased MOR transcription. The increased MOR expression was also confirmed by real-time qRT-PCR using UD and AP4d cells showing about 50-fold increase in AP4d compared to UD cells (Fig. 1B) .
MNase hypersensitivity of the MOR gene promoter region.
To map the location of nucleosomes on the MOR promoter, LM-PCR was performed using specific sets of primers and linkers to amplify MNase-treated P19 genomic DNA ( Fig. 2A) . As the concentration of MNase increased from 20 to 60 units, the LM-PCR produced a band of ~142 bp from the P19 cells (lanes 6 and 7), whereas nonspecific or weaker bands below the 142-bp band were detected throughout all the samples. These nonspecific bands were also detected with differing degrees of This article has not been copyedited and formatted. The final version may differ from this version. PCR product contains a 117-bp fragment derived from nucleosome N1. This fragment mapped to the 5′ border of N1, at the −345 position relative to the translation initiation site (Fig. 2A) . The 142-bp product seen in undifferentiated P19 cells decreased in cells undergoing neuronal differentiation (asterisks, lanes 9 and 11). It is possible that less PCR product was generated from these samples because dissociation of the nucleosome increased the ability of MNase to digest chromatin in this region (compared with nucleosome-compacted regions).
Another LM-PCR using primer set B (located upstream of primer set A) identified a specific band at 82-bp in the UD sample (Fig. 2B, lane 2) , which calculated to the same position at the 5′-border of N1 shown in Figure 2A . This band also decreased in intensity as neuronal differentiation occurred. Interestingly, this N1 region contains a known core promoter site for the MOR gene that has minimal promoter activity by itself (Ko et al., 1997) .
The nonspecific bands in Fig. 2B (arrowhead) were similar in intensity for all the three samples, suggesting equivalent amounts of starting chromatin input for the LM-PCR. However, in Figure 2A the intensity of the nonspecific bands varied somewhat (arrowheads). To confirm that the same amount of input was used for each sample, semi-quantitative PCR was performed.
Intact chromatin DNA was isolated from the same samples used for LM-PCR, diluted serially, and used as PCR templates with two sets of primers covering the DP upstream region and the PP region. The PCR bands generated were similar for each dilution of DNA with either primer regardless of stage of differentiation, confirming that nearly equivalent amounts of chromatin were used for the above LM-PCR ( Fig. 2A, top right) .
This article has not been copyedited and formatted. The final version may differ from this version. (Carey et al., 2009 ). The location of the 5′-border of nucleosome N1 at position −346 (Fig. 2C, lanes 1 and 2) is almost the same as that seen in results from MNase-mediated LM-PCR ( Fig. 2A and B) . Also, are also occurring. The details of this mechanism remain to be addressed in further studies.
Disassembly of nucleosomes on the MOR promoter in differentiated neuronal cells.
Having determined the exact 5′ border of nucleosome N1 on the MOR promoter, we confirmed the presence of other nearby nucleosomes using specific PCR primer sets (Fig. 3A) . In eukaryotes, with very few exceptions, one nucleosome complex occupies 147 bp with a 50-bp spacer (also known as the linker region bound by histone H1) between nucleosomes (Olins and Olins, 2003) . Nucleosome ladders therefore produce fragments separated by approximately 200 bp after nuclease digestion. We therefore designed several PCR primer sets with some overlapping the nucleosome area (Fig. 3A) . Cell nuclei were isolated, completely digested with MNase, and separated on an agarose gel. Mononucleosomal fragments were isolated from an agarose gel (Fig. 3B , left panel) and amplified by PCR using primer pairs specific to a particular This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 3A , top gel). However, using purified monomer DNA as a PCR template, only PCR products from primer sets covering nucleosomes N3, N2, and N1 (Fig.   3A , bottom gel, lanes 2, 4, and 6, respectively) were amplified. Little or no PCR products were generated from primer sets covering the linker regions (L1, L2, and L3). These results demonstrated the exact nucleosome locations surrounding the MOR promoters.
To examine mononucleosome alterations in the promoter during neuronal differentiation, we used real-time qPCR to assess the relative amount of mononucleosomal DNA derived from the N1-specific genomic DNA region. This method allows rapid assessment of the relative amounts of specific nucleosomes formed on a particular genomic DNA segment. Nucleosome N1 of the PP (i.e., the region around the major transcription initiation site) was detected at its highest levels in UD cells and decreased significantly in AP2d and AP4d cells (Fig. 3B , right),
suggesting that "loosening" or dissociation of nucleosome N1 occurs during neuronal differentiation, consistent with increased accessibility to MNase and DNase.
Involvement of Sp transcription factor family members with the MOR promoter region in differentiated neuronal cells during MOR gene activation. Epigenetic changes such as CpG
DNA methylation are associated with chromatin remodeling. The N1 and promoter regions contain several GC boxes (Fig. 4A ). These GC boxes are binding sites for the transcription factor Sp1 Ko et al., 1998) . To determine if these transcription factors are affected by DNA methylation and if transcription factor exchanges occur on this promoter during DNA methylation, we used in vitro-methylated MOR promoter DNA or unmethylated DNA as probes with nuclear extracts from P19 cells in an EMSA assay. When unmethylated DNA was used as a probe (Fig. 4A) The specificity of the antibodies against MeCP2, Sp1, and Sp3 and the expression levels of the proteins were demonstrated by western blotting (Fig. 4C) . Expression of Sp1 and Sp3 gradually decreased during differentiation, whereas the expression level of MeCP2 increased slightly throughout differentiation. Despite their presumed functional roles in the P19 cell system, protein expression levels did not associate closely with MOR mRNA levels, suggesting that absolute protein levels are not as important as the timing and pattern of expression. Additional ChIP assays were performed to examine several signature regulators in gene regulation. Interaction of MeCP2 decreased in differentiated cells (Fig. 5B) , consistent with previous results . Interactions of HDAC1 and HDAC3 as well as mSin3A (a known corepressor for HDACs) also decreased in differentiated cells. The presumed opening of the chromatin structure on the PP-MOR in differentiated cells prompted us to examine the SWI/SNF family of chromatin remodeling complexes (Fig. 5B) . The ATP-dependent chromatinremodeling factor Brg1, but not Brm, was recruited to PP-MOR after differentiation. BAF155
Differentiation induces Sp1 binding to GC boxes and reduces
and Pol II were also recruited to this promoter during differentiation.
Histone modifications on nucleosomes N1 and N2 of the MOR promoter. Because histone
interactions are relatively low in N1 and the MOR promoter region extends into N2, we examined histone modifications by performing ChIP assays using PCR primers covering both nucleosomes (Fig. 5C ). Antibodies against acetylated histones H3 and H4 immunoprecipitated more DNA from differentiated than from UD cells (Fig. 5C ), suggesting that the acetylated forms are enriched on the MOR promoter in differentiated cells. Further ChIP analyses (Fig. 5C) showed reduced methylation of histone H3 dm K9 (a hallmark of gene inactivation), concurrent with increased dimethylation at lysine 4 (a hallmark of gene activation) (Berger, 2001) in the differentiated cells. These results indicate that the histone code is in an active state and that DNA demethylation occurs at the PP in differentiated cells with active MOR expression.
Sp1 activates MOR promoter activity. Overexpressing Sp1 in MOR-positive NMB cells
increased the cotransfected MOR promoter activity about fivefold relative to controls (Fig. 5D ).
Treatment of NMB cells with the HDAC inhibitor TSA resulted in about a 2.4-fold increase in
Discussion
In eukaryotes, DNA methylation and histone modifications represent the major epigenetic mechanisms implicated in the regulation of gene transcription. Methylation of DNA is associated with gene silencing in conjunction with histone core modifications, probably through chromatin remodeling (Berger, 2001; Martinowich et al., 2003) . Chromatin remodeling, especially in the promoter region, is a key regulatory step in transcription, providing DNA accessibility for transcription (or nuclear) factors and transcription complexes (Gilbert et al., 2004) . The nuclear factors' ability to access DNA can be regulated by different chromatin remodeling complexes, which alter DNA-histone contacts by using the energy of ATP hydrolysis (Gilbert et al., 2004; Lusser and Kadonaga, 2003) .
Transcription of the mouse MOR gene is regulated during the differentiation of neuronal P19 cells. The proximal promoter, a major promoter of the MOR gene, is silenced in P19 stem cells. During neuronal development the MOR promoter becomes activated through demethylation of the promoter DNA and dissociation of MeCP2, a methyl-CpG-binding protein ). An epigenetic study of the mouse brain (Hwang et al., 2009 ) showed hypermethylation of the MOR promoter, high levels of MeCP2 bound to the promoter, and corresponding chromatin modifications in the cerebellum, the region of the brain where MOR is expressed at its lowest levels. Also, the highest levels of methylated DNA in the MOR promoter occur in mouse neuroblastoma NS20Y cells, which have the lowest expression levels of the MOR gene among all cultured cells tested in our laboratory (Hwang et al., 2009) . These studies site. This places the 5′ border 54 bases upstream of the first of four known transcription initiation sites (Min et al., 1994) . Interestingly, nucleosome N1 (−345 to −198) covers the MOR core promoter region (−340 to −300), a region that is itself responsible for 70% of the activity of the whole promoter (Ko et al., 1997) . Furthermore, nucleosome N1 dissociation allows access for transcription factors when the MOR gene is active in differentiated cells. That is, in its inactive state the major MOR promoter region is covered by nucleosome N1, but when active, the promoter is free of nucleosome complexes, thus exposing binding sites for transcription factors and permitting gene activation. It was therefore important to determine if other epigenetic This article has not been copyedited and formatted. The final version may differ from this version. We examined factors involved in chromatin alteration of N1 and its surrounding regions because theses regions overlapped with several GC boxes and the transcription initiation sites of the MOR gene. Among the five GC boxes studied, all of which serve as binding sites for Sp family members, three are located inside N1. Transcriptional regulation by members of the Sp family of transcription factors has been reviewed extensively (Kaczynski et al., 2003; Suske, 1999) . Sp1 functions mainly as a transcriptional activator while Sp3 is a bifunctional factor with three different isoforms, and its activities can be regulated in part by the relative expression of these isoforms (Hernandez et al., 2004; Kennett et al., 2002) . Drosophila SL2 cells do not endogenously express Sp family proteins (Courey and Tjian, 1988; Schneider, 1972) . When these cells were cotransfected with Sp factors and MOR promoter plasmids, Sp1 and Sp3 stimulated MOR promoter activity 4.4-and 2-fold, respectively (Choi et al., 2005) . Interestingly, genes (Hernandez et al., 2004; Kennett et al., 2002) . Expression of the multiple isoforms of Sp3 is controlled by alternative translation initiations, with each isoforms having a unique role leading to either activation or repression of the MOR gene.
There is increasing evidence that chromatin-remodeling factors are involved in several biological events, including cancer development (Dey, 2006; Guasconi and Ait-Si-Ali, 2004; Medina and Cespedes, 2008) , ovarian germ and somatic cell development and differentiation (Pepin et al., 2007) , neuronal differentiation (Lessard et al., 2007; Seo et al., 2005) , DNA damage repair (Pena and Pereira-Smith, 2007) , embryonic stem cell neuronal differentiation (Meshorer, 2007) , aging (Anastasiou and Krek, 2006) , and immune cell development (Winandy, 2005) . These findings indicate that chromatin remodeling plays an important role in gene regulation. Alteration of nucleosomes by ATP-dependent remodeling complexes represents a critical step in the regulation of transcription. Therefore, we investigated the involvement of chromatin remodeling factors from the human SWI/SNF family in MOR gene-activated cells.
This family is composed of complexes that contain either Brg1 or hBrm as the central ATPase.
Brg1, an ATP-dependent chromatin-remodeling factor, and BAF155 were recruited to the MOR promoter in MOR-activated cells. Surprisingly, binding of Brm to the MOR promoter was lower in MOR-activated cells than in MOR-negative cells. However, differential roles for these two factors have been suggested in the kappa opioid receptor promoter (Park et al., 2005) . Although
Brm is generally known as a global transcriptional activator of homeotic genes (Tamkun et al., 1992) , it also can act as a transcriptional suppressor (Brumby et al., 2002; Zhang et al., 2000) .
One recent report showed that Brm interacts with MeCP2, a major epigenetic regulator, suggesting Brm's role in epigenetic repressor complexes (Harikrishnan et al., 2005) . However, another group has reported contradictory results (Hu et al., 2006) . In our laboratory, MeCP2 did This article has not been copyedited and formatted. The final version may differ from this version. showing a direct association between chromatin remodeling complexes and proteins involved in gene repression (Sif et al., 2001) . Although Brm and Brg1 have very high homology in their protein sequences, they have differential expression profiles in human tissues (Reisman et al., 2005) , suggesting that they might have different functions in chromatin remodeling complexes.
In summary, here we report the exact location of the nucleosome complexes surrounding the major MOR promoter region. These nucleosomes dissociate when the gene is transcriptionally active, concurrent with histone modifications and interactions with chromatin remodeling factors. Based on the results of the present study, we propose the following model ( Schematic of the MOR gene promoters (DP: distal promoter; PP: proximal promoter) and the first exon. The minor DP (−794, relative to the translation start codon at +1) has a single transcription initiation site (Ko et al., 1997) , whereas the major PP has four (Min et al., 1994) .
Locations of the probes used in Fig. 1A Primers specific for nucleosome position N1 of the MOR gene promoter (S-342 and AS-229; see Table 1 ) were used to amplify genomic DNA sequences present in immunoprecipitates by ChIP-PCR. Amplification of soluble chromatin before precipitation was used as an input control.
Antibodies for each ChIP reaction are indicated on top (A) or the side (B) of each gel image.
Parallel controls were performed without antibody, or using a nonspecific antibody (anti-Gal4).
Images are representative of at least two experiments. C. ChIP analyses to detect chromatin modification on the N1 and N2 positions of the MOR promoter. Primers specific for the N1 and N2 locations (S-497 and AS-182; Table 1) promoter construct also were exposed to TSA. Cells were harvested 48 h after transfection, lysed, and assayed for luciferase activity. Promoter activity was normalized by protein concentration. 
